Position: Chairman (since 7 January 2026)
Number of shares in Navamedic ASA: 30,786
Other current directorships: Chairman of Genetic Analysis AS, Board member of Atea ASA and Defibrio AS.
Year of birth: 1960

Experience:
Jurs has served on the board of Navamedic ASA since June 2025 and assumed the role of Chairman in January 2026. He was previously CEO of SpinChip Diagnostics from 2021 to 2025. Before that, he was a Partner at the investment company Pegasus Industrier. His earlier experience includes leadership roles as CEO of Stamina Group, CEO and CFO of Pronova BioPharma ASA, and CFO at Kitron ASA. Jurs currently operates his own consultancy business.

Education:
Jurs holds a Master in Business and Finance from University of Wyoming.